Mirati Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

980,029

Value ($000)

57,586

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	57,586	0.0%	980,029	12/31/2023
2023 Q3	11/13/2023	38,393	0.0%	881,226	9/30/2023
2023 Q2	8/11/2023	27,621	0.0%	764,483	6/30/2023
2023 Q1	5/15/2023	27,338	0.0%	735,288	3/31/2023
2022 Q4	2/13/2023	32,049	0.0%	707,345	12/31/2022
2022 Q3	11/14/2022	45,811	0.0%	655,950	9/30/2022
2022 Q2	8/12/2022	43,436	0.0%	647,050	6/30/2022
2022 Q1	5/13/2022	52,483	0.0%	638,329	3/31/2022
2021 Q4	2/11/2022	90,354	0.0%	615,953	12/31/2021
2021 Q3	11/12/2021	99,219	0.0%	560,849	9/30/2021
2021 Q2	8/13/2021	91,939	0.0%	569,179	6/30/2021
2021 Q1	5/12/2021	129,269	0.0%	754,636	3/31/2021
2020 Q4	2/12/2021	153,469	0.0%	698,735	12/31/2020
2020 Q3	11/13/2020	95,512	0.0%	575,202	9/30/2020
2020 Q2	8/13/2020	65,236	0.0%	571,399	6/30/2020
2020 Q1	5/14/2020	39,130	0.0%	509,054	3/31/2020
2019 Q4	2/13/2020	56,890	0.0%	441,493	12/31/2019